[1]
Jia, N. 2025. Evaluating the Efficacy of Immune Checkpoint Inhibitors Across Different Cancer Types: Focusing on Lung Cancer, Breast Cancer and Melanoma. Transactions on Materials, Biotechnology and Life Sciences. 8, (Oct. 2025), 39–44. DOI:https://doi.org/10.62051/8hkm3p85.